These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10464658)

  • 1. Practice variations in biochemical screening for Down syndrome.
    Lenke RR; Walkowicz K; Baker K
    Genet Test; 1997-1998; 1(4):279-81; discussion 282. PubMed ID: 10464658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists.
    Cleary-Goldman J; Morgan MA; Malone FD; Robinson JN; D'Alton ME; Schulkin J
    Obstet Gynecol; 2006 Jan; 107(1):11-7. PubMed ID: 16394034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
    Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
    Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
    Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
    Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down syndrome prevention program in a population with an older maternal age.
    Shohat M; Legum C; Romem Y; Borochowitz Z; Bach G; Goldman B
    Obstet Gynecol; 1995 Mar; 85(3):368-73. PubMed ID: 7862374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quadruple test for Down syndrome screening in pregnant women of advanced maternal age.
    Kwon JY; Park IY; Kwon SM; Kim CJ; Shin JC
    Arch Gynecol Obstet; 2012 Mar; 285(3):629-33. PubMed ID: 21837420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of genetic counseling on decisions of pregnant women aged 35 years or over regarding amniocentesis in Turkey.
    Ilgin-Ruhi H; Yürür-Kutlay N; Tükün A; Bökesoy I
    Eur J Med Genet; 2005; 48(1):13-9. PubMed ID: 15953401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Down syndrome: changing practice of obstetricians.
    Driscoll DA; Morgan MA; Schulkin J
    Am J Obstet Gynecol; 2009 Apr; 200(4):459.e1-9. PubMed ID: 19318157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the use of prenatal diagnosis in New York State and the impact of biochemical screening on the detection of Down syndrome: 1984-1993.
    Olsen CL; Cross PK
    Prenat Diagn; 1997 Dec; 17(12):1113-24. PubMed ID: 9467808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating first-trimester Down syndrome studies into prenatal screening: executive summary of the National Institute of Child Health and Human Development workshop.
    Reddy UM; Mennuti MT
    Obstet Gynecol; 2006 Jan; 107(1):167-73. PubMed ID: 16394055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thoughts about screening for Down syndrome].
    Gardó S
    Orv Hetil; 2009 Mar; 150(11):497-501; discussion 501-2. PubMed ID: 19258245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
    Chen CP; Chern SR; Liu FF; Jan SW; Lee CC; Chang YC; Yue CT
    Prenat Diagn; 1997 Jun; 17(6):571-6. PubMed ID: 9203216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.